Alnylam Pharmaceuticals | Zinsaufwendungen Für Schuld



Interest Expense On Debt Veränderung Datum
Acadia Pharmaceuticals 0 4.12M 2024-09
Agios Pharmaceuticals 3.01M 10.05M 2024-12
Alnylam Pharmaceuticals USD 38.97M 4.6M 2024-12
Amgen USD 747M 29M 2024-12
Arrowhead Research USD 21.65M 7M 2024-12
BioMarin Pharmaceutical USD 2.58M 391K 2024-12
Incyte USD 419K 355K 2024-12
Ionis Pharmaceuticals USD 2.59M 70K 2024-12
Moderna USD 6M 0 2024-12
Neurocrine Biosciences USD 1.1M 0 2024-03
Novartis USD 275M 11M 2024-12
PTC Therapeutics USD 43.35M 1.24M 2024-12
Regeneron Pharmaceuticals USD 10.5M 3.3M 2024-12
Sanofi 66.11M 20.67M 2024-12
Sarepta Therapeutics USD 4.92M 86K 2024-09
Takeda 31.6B 36.86B 2024-12
Tectonic Therapeutic USD 22K 3K 2024-12
Ultragenyx Pharmaceutical 15.52M 190K 2024-12
Vertex Pharmaceuticals USD 2.8M 4.7M 2024-12
Xencor -39359000 40.15M 2024-12



Alnylam Pharmaceuticals Zinsaufwendungen Für Schuld - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Apr 2025.